UK biotech funding hits £2.8bn as AI deals reshape sector
UK biotech venture funding rose 44% to £270m in Q3, lifting 2025 investment to £2.8bn — the strongest year since 2021 — despite a 17-quarter IPO drought.
Topic
Topic
UK biotech venture funding rose 44% to £270m in Q3, lifting 2025 investment to £2.8bn — the strongest year since 2021 — despite a 17-quarter IPO drought.